Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities
Zhe Jiang,
No information about this author
Michelle S. Allkanjari,
No information about this author
Philip E.D. Chung
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(5), P. 720 - 720
Published: Feb. 20, 2025
Pineoblastoma
(PB)
is
a
rare
yet
lethal
pediatric
brain
cancer
of
the
pineal
gland,
small
endocrine
organ
that
secretes
melatonin
to
regulate
circadian
rhythm.
For
PB
patients
≤5
years
age,
overall
survival
rate
approximately
15%;
metastatic
incurable.
Standard
treatment,
including
surgical
resection,
radiation,
and
systemic
chemotherapy,
improves
but
compromises
neurocognitive
function.
A
better
understanding
disease
generation
preclinical
models
may
enable
re-evaluation
previous
clinical
trials,
development
precision
therapeutic
strategies
improve
patient
outcome.
Over
past
5
years,
has
been
recognized
include
several
major
subtypes
driven
by
(i)
loss
microRNA
processing
factors
DICER
DROSHA
characterized
relatively
good
prognosis;
(ii)
retinoblastoma
tumor
suppressor
RB1;
(iii)
amplification
or
induction
cMYC
protooncogene,
with
latter
two
exhibiting
exceedingly
poor
prognosis.
Recently,
mouse
for
(RB1-,
DICER1-
DROSHA-)
except
MYC-
have
established.
This
progress,
disease,
cell
origin,
progression,
role
autophagy,
targetable
vulnerabilities,
holds
promise
novel
combat
each
subtype
this
childhood
malignancy.
Language: Английский
Spatial single cell transcriptomic analysis of a novel DICER1 Syndrome GEMM informs the cellular origin and developmental hierarchy of associated sarcomas
F. Kommoss,
No information about this author
Joyce Zhang,
No information about this author
Branden Lynch
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 5, 2024
Abstract
DICER1
syndrome
predisposes
children
and
young
adults
to
tumor
development
across
various
organs.
Many
of
these
cancers
are
sarcomas,
which
uniquely
express
the
RNase
IIIb
domain-deficient
form
exhibit
consistent
histological
molecular
similarities
regardless
their
anatomical
origins.
To
uncover
cellular
origin
developmental
hierarchy,
we
established
a
lineage-traceable
genetically
engineered
mouse
model
that
allows
for
precise
activation
Dicer1
mutations
in
Hic1
+
mesenchymal
stromal
cells.
This
resulted
renal
tumors
closely
mirroring
human
sarcoma
histologically
molecularly.
Single-cell
transcriptomics
coupled
with
targeted
spatial
gene
expression
analysis
revealed
progenitor
population
marked
by
Pdgfra
,
Dpt
Mfap4,
corresponding
universal
fibroblasts
steady-state
kidneys.
These
fibroblastic
progenitors
capacity
undergo
rhabdomyoblastic
differentiation
or
transition
highly
proliferative
anaplastic
sarcoma.
Investigation
patient
samples
identified
analogous
cell
states.
study
uncovers
provides
faithful
mechanistic
investigation
therapeutic
within
rhabdomyosarcoma
spectrum.
Language: Английский